Latest News
Gala Crypto Price Prediction: Should You Buy After the Latest Decline?
Key points: Despite multiple activities, the Gala coin price has fallen by 55.46% in 2022. Gala Games is revolutionising the gaming industry by empowering gamers. If
Avalanche (AVAX) Crypto Price Prediction: Should You Buy the Token?
Key points: The Avalance crypto fell in April amid the border crypto selloff. Avalanche is positioned as a leading competitor against Ethereum. AVAX prices are curre
TRON (TRX) Crypto Price Prediction: Can It Reclaim Its March Highs?
Key points: The TRON crypto price fell 17% in April. Can it reclaim its March highs? The crypto seems to have bottomed and could be heading higher soon. However, th
The Kyber Network (KNC) Crypto Price Prediction: Will It Keep Rising?
Key points: The KNC crypto price has soared by 240.5% in 2022. Will it keep rising? The token has risen due to the Kyber Network’s popularity among traders. The KNC
Buy IBM (IBM) Amid Uncertainty, Says Morgan Stanley Analyst
Key points: IBM shares edged higher on positive upgrade from Morgan Stanley analyst Erik Woodring sees IBM shares as a safe play amid growing macro uncertainty IBM is
Sonim Technologies (SONM) Rallies 10.7% on $17.5M Equity Transaction
Key points: SONM shares rallied over 10% on news of a $17.5M subscription agreement with AJP Holding Company The transaction will allow the company to expand into semi-rugged pro
Is Netflix (NFLX) Stock a Buy or Sell Ahead of Earnings?
Key points: NFLX stock is down over 40% YTD, will we see any relinquishment in the share price after next weeks earnings? Pivotal changes such as ad-driven accounts, and password
Akash Network (AKT) Price Prediction: Can the Token Break Above $2?
Key points: The Akash Network is known as the Airbnb of cloud computing. However, the AKT token is trading at $1.2068 is a long way from $2. Here’s what needs to hap
Wells Fargo (WFC) Stock Drops 3.5% on Sharp Drop In Mortgage Lending
Key points: WTC shares dropped 3.5% on weaker than expected revenue Although earnings were solid following lowered credit reserves, lower mortgage lending weighed on revenue
Kaleido Biosciences (KLDO) Stock Soared 100%+ in Two Days Despite Liquidation
Key points: Kaleido Biosciences stock rallied 140%+ in two days despite liquidation. The firm is set to cease operations after a strategic review of its business. It
Twitter Stock Jumped 13% on Elon Musk’s $43B Acquisition Offer. Is It a Buy?
Key points: Twitter shares gapped 13% premarket on Elon Musk’s acquisition offer. Musk has offered to buy Twitter’s remaining shares at $54.20 each ($43 bn). Investo
Sound Energy (SOU) Shares Surged 21% on Operations, Strategy Update
Key points: Sound Energy shares surged 21% after releasing an operations update. The transition energy company also issued an update about its strategy. Investors ch
Clarus Therapeutics, CRXT, Jumps Near 100% – Why?
Key points: Clarus Therapeutics stock has jumped near 100% in the last 24 hours This is not what we expect from a filing for stock issuance Nor is this what the leap in sh
Will Helium One Shares Benefit From the Global Helium Supply Shortage?
Key points: Helium One could benefit significantly from rising global helium demand. First, the firm has to start producing helium to benefit from the prices. Invest
Horizonte Minerals, HZM, Jumps On Glencore Buying – Validation?
Key points: Horizonte Just Bagged Glencore as a major investor The is a validation, but not a proof This might be viewed as Glencore taking an option
Darktrace Drops On End Of Post-IPO Lock-Up – Is This The Only Problem?
Key points: Darktrace dropped 11.6% yesterday on IPO lockup news It’s expected that up to 20 million shares will hit the market Some recovery today, but is this the only p
Will Petropavlovsk Be Driven Bust By Sanctions?
Key points: Petropavlovsk is in that archetypal between rock and hard place They can’t obey current sanctions laws and meet contractual agreements So, will Petropavlovsk b
Can the Synairgen Share Price Recover After Falling 89% This Year?
Key points: Synairgen shares fell after its SNG001 COVID-19 drug failed its phase 3 trial. However, there is hope for the company in the COVID-19 vaccine space. Stil
IAG Could Be Boosted By Delta’s Traffic Announcement – But Will It?
Key points: IAG depends, more than other London airlines, on long haul traffic